PharmaCyte Biotech, Inc.
PMCB
$0.72
-$0.03-3.73%
NASDAQ
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 20.54M | 15.61M | 13.44M | 15.54M | 16.76M |
| Total Receivables | -- | 5.00M | 4.61M | 3.70M | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 158.70K | 503.10K | 238.20K | 223.80K | 207.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 1.91M | 820.00K | 2.92M | -- |
| Total Current Assets | 20.70M | 23.02M | 19.11M | 22.38M | 16.96M |
|
|
|||||
| Total Current Assets | 20.70M | 23.02M | 19.11M | 22.38M | 16.96M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.55M | 1.55M | 1.55M | 1.55M | 1.55M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.16M | 10.66M | 4.82M | 8.77M | 6.69M |
| Total Assets | 55.87M | 55.98M | 45.11M | 55.17M | 43.83M |
|
|
|||||
| Total Accounts Payable | 1.20M | 1.02M | 465.20K | 399.20K | 484.90K |
| Total Accrued Expenses | 345.70K | 345.70K | 345.70K | 521.10K | 709.40K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 132.50K | 210.40K | 250.00K | 1.99M | -- |
| Total Other Current Liabilities | 132.50K | 210.40K | 250.00K | 1.99M | -- |
| Total Current Liabilities | 1.68M | 1.58M | 1.06M | 2.91M | 1.19M |
|
|
|||||
| Total Current Liabilities | 1.68M | 1.58M | 1.06M | 2.91M | 1.19M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 14.79M | 17.85M | 458.00K | 363.00K | 2.38M |
| Total Liabilities | 16.47M | 19.42M | 1.52M | 3.28M | 3.58M |
|
|
|||||
| Common Stock & APIC | 183.14M | 180.61M | 181.55M | 181.49M | 181.43M |
| Retained Earnings | -100.00M | -100.75M | -93.33M | -84.97M | -96.72M |
| Treasury Stock & Other | -44.61M | -44.22M | -44.63M | -44.63M | -44.46M |
| Total Common Equity | 38.53M | 35.65M | 43.59M | 51.89M | 40.25M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 872.30K | 902.00K | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 872.30K | 902.00K | -- | -- | -- |
|
|
|||||
| Total Common Equity | 38.53M | 35.65M | 43.59M | 51.89M | 40.25M |
| Total Preferred Equity | 872.30K | 902.00K | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 39.40M | 36.55M | 43.59M | 51.89M | 40.25M |
|
|
|||||